Botox Rival Likely to get FDA Approval


Top Procedures BOTOX® Chemical Peels Fotofacial / IPL Fraxel JUVEDERM® LATISSE® Mesotherapy Restylane Smart Lipo VelaShape
Skin Conditions Acne Acne Scars Age Spots Cellulite Eczema Facial Veins Fine Lines & Wrinkles Freckles Liver Spots Melanoma Melasma Moles Psoriasis Rosacea Sun Spots Vitiligo Laser Liposuction Cool Lipo Laser Liposuction Lipolite Laser Liposculpture Lipotherme ProLipo PureLipo Slim Lipo Smart Lipo Smartlipo MPX SmoothLipo Vaser Liposelection Zerona Laser Liposuction Body Contouring Accent XL Aluma Body Jet Liposuction CoolSculpting LipoDissolve Mesotherapy Refirme Thermacool Thermage® Titan® Injectables & Fillers ArteFill Belotero Balance BOTOX® Captique Collagen Cosmoplast/Cosmoderm Dermal Fillers Dysport Elevess Evolence Hylaform® JUVEDERM® Lip Enhancement Perlane Prevelle Silk Purtox Radiesse™ Restylane® Sculptra™ Vitrase Acne Scar Treatments Blue Light Smoothbeam Anti-Aging Treatments Epidermal Leveling FotoFacial™/IPL Treatments Genesis Skin Rejuvenation Liquid Facelift Pelleve Revlite Rejuvenation Skin Tyte Threadlift Triniti Cellulite Treatments Acoustic Wave Therapy SmoothShapes TriActive Velashape VelaSmooth Fractional Resurfacing Active FX Deep FX Fractional Resurfacing Fractional Resurfacing Fraxel Fraxel re:pair Fraxel re:store Laser Resurfacing Palomar 1540 Fractional Resurfacing Palomar Fractional Resurfacing Profractional Resurfacing SmartXide Dot Therapy Cosmetic Enhancement Acne Treatment Blue Peel Chemical Peels Cosmelan Dermabrasion Hyperhidrosis BOTOX® Treatment Isolaz Laser 360 Laser Hair Removal Laser Tattoo Removal LATISSE® Microdermabrasion Photodynamic Therapy Skin Care & Cosmetic Products Skin Rejuvenation Sunless Tanning VI Peel Vitalize Peel
Training Courses For Physicians Email A Friend This Page Insurance Info Resources Skin Care Information Testimonials

Home

About Us

FAQs

Blog Home –› Botox Rival Likely to get FDA Approval

Botox Rival Likely to get FDA Approval

The newest trend to hit cosmetic dermatology is a rival to industry leader Botox. Medicis Pharmaceutical Corp is releasing Reloxin an anti-wrinkle and anti-aging injection likely to get FDA approval shortly. The approval was scheduled to have been this coming month, however the FDA is taking extra precaution prior to doing so. Reloxin however has seen successful wrinkle-ridding with very few side effects in test-patients.

Reuters reported on the new product saying, "Analysts expect Reloxin to bring in between $25 million and $50 million in the second half of 2009, while Botox sales totaled $1.31 billion in 2008. Medicis is expected to launch the injectable drug at a discount to Botox, but Allergan could counter through rebates and coupons and by bundling its diverse aesthetic products into value-added packages for customers."

Very rarely has a Botox rival emerged in the market and successfully surpassed the Allergen conglomerate. Die hard Botox fans are not keen to swap over from their quarterly Botox pricks, so this will have to be marketed adroitly before people catch onto it.

Posted by Tala on 3/18/2009 9:36:34 AM

Most Recent Posts

Top Cities for Smart Lipo

More Cities

PHYSICIANS LIST YOUR PRACTICE

Copyright © 2012 HealthNews.org. All Rights Reserved. Do not use this website as a substitute for medical care. Please consult your physician or other medical care provider regarding any medical questions you may have.

DermaNetwork is an informational site to find doctors & specialists dealing with awareness, problems, treatments, and costs associated with skin care.

Most Recent Posts

Previous Posts